Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

522
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
522
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

339
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
339
Dementia01:30

Dementia

297
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
297

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facial feature removal in magnetic resonance imaging scans of adults with Down syndrome: A de-facing methodological study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Operationalizing diffusion magnetic resonance imaging positivity for detection of vascular contributions to impairment and dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Overnight sleep features and next-morning brain metabolism in older adults.

Sleep medicine·2026
Same author

Reflections on rural community characteristics by an outreach, recruitment, and engagement team.

Journal of Alzheimer's disease : JAD·2026
Same author

Variability in Clinical Performance of the FDA-Cleared Lumipulse P-Tau217/β-Amyloid 1-42 Plasma Ratio.

JAMA neurology·2026

Related Experiment Video

Updated: Nov 22, 2025

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.3K

Cognitive Impairment in Patients with Stroke.

Caitlin E D'Souza1,2, Melanie R F Greenway1, Jonathan Graff-Radford3

  • 1Department of Neurology, Mayo Clinic Florida, Jacksonville, Florida.

Seminars in Neurology
|January 8, 2021
PubMed
Summary

Vascular cognitive impairment is a major cause of disability after stroke, affecting up to 30% of patients. Early awareness and research are crucial for developing effective treatments for this condition.

More Related Videos

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.3K
Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
05:23

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients

Published on: March 11, 2021

2.7K

Related Experiment Videos

Last Updated: Nov 22, 2025

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.3K
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.3K
Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients
05:23

Motor Dual-Tasks for Gait Analysis and Evaluation in Post-Stroke Patients

Published on: March 11, 2021

2.7K

Area of Science:

  • Neurology
  • Geriatrics
  • Public Health

Background:

  • Vascular cognitive impairment (VCI) is a significant cause of disability post-stroke.
  • Cognitive decline often persists after stroke, unlike sensorimotor deficits.
  • The aging population will increase VCI prevalence, with stroke as a key factor.

Purpose of the Study:

  • To highlight the impact of stroke on cognitive function.
  • To discuss the relationship between stroke, dementia, and cognitive impairment.
  • To emphasize the need for improved VCI management and research.

Main Methods:

  • Review of existing literature on stroke and cognitive impairment.
  • Analysis of prevalence data for dementia post-stroke.
  • Discussion of current treatment strategies and research gaps.

Main Results:

  • 10% of stroke patients have pre-stroke dementia; 10-30% develop incident dementia after stroke.
  • Cognitive impairment nearly doubles the risk of poor outcomes after stroke.
  • Overlap exists between vascular and degenerative dementias, with controversial relationships.

Conclusions:

  • Supportive care and vascular risk factor management are current VCI treatments.
  • Cognitive rehabilitation shows promise but requires more research.
  • Increased awareness of VCI in stroke patients is vital for better prognostication, management, and treatment discovery.